Long-Term Kidney and Systemic Effects Of Calorie Restriction in Overweight or Obese Type 2 Diabetic Patients (C.Re.S.O. 2 Randomized Controlled Trial).

[1]  R. DeFronzo,et al.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors , 2021, Nature Reviews Nephrology.

[2]  J. McMurray,et al.  Dapagliflozin in Patients with Chronic Kidney Disease. , 2020, The New England journal of medicine.

[3]  E. Porrini,et al.  The estimation of GFR and the adjustment for BSA in overweight and obesity: a dreadful combination of two errors , 2019, International Journal of Obesity.

[4]  W. Kraus,et al.  2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. , 2019, The lancet. Diabetes & endocrinology.

[5]  A. Chagnac,et al.  Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity , 2019, Nephron.

[6]  Deepak L. Bhatt,et al.  Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.

[7]  S. Lim,et al.  Long-term prospective observation suggests that glomerular hyperfiltration is associated with rapid decline in renal filtration function: A multiethnic study , 2018, Diabetes & vascular disease research.

[8]  M. Grams,et al.  Kidney Function in Obesity-Challenges in Indexing and Estimation. , 2018, Advances in chronic kidney disease.

[9]  E. Guallar,et al.  Metabolically Healthy Obesity and Development of Chronic Kidney Disease , 2016, Annals of Internal Medicine.

[10]  G. Remuzzi,et al.  Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled Trial , 2016, Diabetes.

[11]  V. D’Agati,et al.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis , 2016, Nature Reviews Nephrology.

[12]  John M Lachin,et al.  Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. , 2016, The New England journal of medicine.

[13]  M. Rewers,et al.  Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  H. Lamb,et al.  Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. , 2014, The lancet. Diabetes & endocrinology.

[15]  D. Elbourne,et al.  Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects☆ , 2014, Journal of clinical epidemiology.

[16]  U. Broedl,et al.  Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus , 2014, Circulation.

[17]  T. Wadden,et al.  Obesity , 1957, Annals of Internal Medicine.

[18]  G. Remuzzi,et al.  Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes , 2012, Diabetes Care.

[19]  D. Cherney,et al.  Renal hyperfiltration related to diabetes mellitus and obesity in human disease. , 2012, World journal of diabetes.

[20]  P. Barter,et al.  Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. , 2011, Circulation.

[21]  M. Burnier,et al.  Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  M. Myśliwiec,et al.  Renal consequences of obesity. , 2010, Medical science monitor : international medical journal of experimental and clinical research.

[23]  G. Remuzzi,et al.  Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial , 2010, Journal of ophthalmology.

[24]  D. Sviridov,et al.  High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.

[25]  U. Gafter,et al.  Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  D. Levy,et al.  Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  A. Rudich,et al.  Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men , 2007, Annals of Internal Medicine.

[28]  B. Dimitrov,et al.  Insulin Resistance and Microalbuminuria , 2006, Diabetes.

[29]  T. Weinstein,et al.  The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.

[30]  S. Bingham,et al.  Urine nitrogen as a biomarker for the validation of dietary protein intake. , 2003, The Journal of nutrition.

[31]  Homer W. Smith.  Nephron adaptation to renal injury or ablation , 2003 .

[32]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[33]  A. Mark,et al.  Obesity-Induced Hypertension , 1999 .

[34]  G. Viberti,et al.  Glomerular Hyperfiltration in the Prediction of Nephropathy in IDDM: A 10-Year Follow-Up Study , 1996, Diabetes.

[35]  N. Perico,et al.  Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. , 1995, Journal of the American Society of Nephrology : JASN.

[36]  H. Mulec,et al.  Renal protective effect of enalapril in diabetic nephropathy. , 1992 .

[37]  T. Hedner,et al.  Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. , 1992, Blood pressure.

[38]  B. Brenner,et al.  Progressive renal disease: a disorder of adaptation. , 1989, The Quarterly journal of medicine.

[39]  John Gormally,et al.  The assessment of binge eating severity among obese persons. , 1982, Addictive behaviors.